Cargando…
Serological response to SARS‐CoV‐2 is attenuated in patients with inflammatory bowel disease and can affect immunization
In this study we indicated that impaired serological responses to SARS‐CoV‐2 infection among patients with IBD, could have significant implications for this group of patients and should be considered in vaccination program.[Image: see text]
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wiley Publishing Asia Pty Ltd
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021711/ https://www.ncbi.nlm.nih.gov/pubmed/35475199 http://dx.doi.org/10.1002/jgh3.12725 |
| _version_ | 1784689891998695424 |
|---|---|
| author | Ghavami, Shaghayegh Baradaran Shahrokh, Shabnam Asadzadeh Aghdaei, Hamid Khoramjoo, Seyed Mobin Farmani, Maryam Kazemifard, Nesa Parigi, Tommaso Lorenzo Danese, Silivio Balaii, Hedieh Sherkat, Ghazal Ebrahimi Daryani, Nasser Alborzi, Foroogh Vossoughinia, Hassan Zali, Mohammad Reza |
| author_facet | Ghavami, Shaghayegh Baradaran Shahrokh, Shabnam Asadzadeh Aghdaei, Hamid Khoramjoo, Seyed Mobin Farmani, Maryam Kazemifard, Nesa Parigi, Tommaso Lorenzo Danese, Silivio Balaii, Hedieh Sherkat, Ghazal Ebrahimi Daryani, Nasser Alborzi, Foroogh Vossoughinia, Hassan Zali, Mohammad Reza |
| author_sort | Ghavami, Shaghayegh Baradaran |
| collection | PubMed |
| description | In this study we indicated that impaired serological responses to SARS‐CoV‐2 infection among patients with IBD, could have significant implications for this group of patients and should be considered in vaccination program.[Image: see text] |
| format | Online Article Text |
| id | pubmed-9021711 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Wiley Publishing Asia Pty Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90217112022-04-25 Serological response to SARS‐CoV‐2 is attenuated in patients with inflammatory bowel disease and can affect immunization Ghavami, Shaghayegh Baradaran Shahrokh, Shabnam Asadzadeh Aghdaei, Hamid Khoramjoo, Seyed Mobin Farmani, Maryam Kazemifard, Nesa Parigi, Tommaso Lorenzo Danese, Silivio Balaii, Hedieh Sherkat, Ghazal Ebrahimi Daryani, Nasser Alborzi, Foroogh Vossoughinia, Hassan Zali, Mohammad Reza JGH Open Brief Reports In this study we indicated that impaired serological responses to SARS‐CoV‐2 infection among patients with IBD, could have significant implications for this group of patients and should be considered in vaccination program.[Image: see text] Wiley Publishing Asia Pty Ltd 2022-03-17 /pmc/articles/PMC9021711/ /pubmed/35475199 http://dx.doi.org/10.1002/jgh3.12725 Text en © 2022 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Brief Reports Ghavami, Shaghayegh Baradaran Shahrokh, Shabnam Asadzadeh Aghdaei, Hamid Khoramjoo, Seyed Mobin Farmani, Maryam Kazemifard, Nesa Parigi, Tommaso Lorenzo Danese, Silivio Balaii, Hedieh Sherkat, Ghazal Ebrahimi Daryani, Nasser Alborzi, Foroogh Vossoughinia, Hassan Zali, Mohammad Reza Serological response to SARS‐CoV‐2 is attenuated in patients with inflammatory bowel disease and can affect immunization |
| title | Serological response to SARS‐CoV‐2 is attenuated in patients with inflammatory bowel disease and can affect immunization |
| title_full | Serological response to SARS‐CoV‐2 is attenuated in patients with inflammatory bowel disease and can affect immunization |
| title_fullStr | Serological response to SARS‐CoV‐2 is attenuated in patients with inflammatory bowel disease and can affect immunization |
| title_full_unstemmed | Serological response to SARS‐CoV‐2 is attenuated in patients with inflammatory bowel disease and can affect immunization |
| title_short | Serological response to SARS‐CoV‐2 is attenuated in patients with inflammatory bowel disease and can affect immunization |
| title_sort | serological response to sars‐cov‐2 is attenuated in patients with inflammatory bowel disease and can affect immunization |
| topic | Brief Reports |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021711/ https://www.ncbi.nlm.nih.gov/pubmed/35475199 http://dx.doi.org/10.1002/jgh3.12725 |
| work_keys_str_mv | AT ghavamishaghayeghbaradaran serologicalresponsetosarscov2isattenuatedinpatientswithinflammatoryboweldiseaseandcanaffectimmunization AT shahrokhshabnam serologicalresponsetosarscov2isattenuatedinpatientswithinflammatoryboweldiseaseandcanaffectimmunization AT asadzadehaghdaeihamid serologicalresponsetosarscov2isattenuatedinpatientswithinflammatoryboweldiseaseandcanaffectimmunization AT khoramjooseyedmobin serologicalresponsetosarscov2isattenuatedinpatientswithinflammatoryboweldiseaseandcanaffectimmunization AT farmanimaryam serologicalresponsetosarscov2isattenuatedinpatientswithinflammatoryboweldiseaseandcanaffectimmunization AT kazemifardnesa serologicalresponsetosarscov2isattenuatedinpatientswithinflammatoryboweldiseaseandcanaffectimmunization AT parigitommasolorenzo serologicalresponsetosarscov2isattenuatedinpatientswithinflammatoryboweldiseaseandcanaffectimmunization AT danesesilivio serologicalresponsetosarscov2isattenuatedinpatientswithinflammatoryboweldiseaseandcanaffectimmunization AT balaiihedieh serologicalresponsetosarscov2isattenuatedinpatientswithinflammatoryboweldiseaseandcanaffectimmunization AT sherkatghazal serologicalresponsetosarscov2isattenuatedinpatientswithinflammatoryboweldiseaseandcanaffectimmunization AT ebrahimidaryaninasser serologicalresponsetosarscov2isattenuatedinpatientswithinflammatoryboweldiseaseandcanaffectimmunization AT alborziforoogh serologicalresponsetosarscov2isattenuatedinpatientswithinflammatoryboweldiseaseandcanaffectimmunization AT vossoughiniahassan serologicalresponsetosarscov2isattenuatedinpatientswithinflammatoryboweldiseaseandcanaffectimmunization AT zalimohammadreza serologicalresponsetosarscov2isattenuatedinpatientswithinflammatoryboweldiseaseandcanaffectimmunization |